Magenta Therapeutics Inc.

NASDAQ: MGTA · Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM

Magenta Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-84.97M -76.46M -71.14M
Depreciation & Amortization
412K 1.93M 2.02M
Stock-Based Compensation
12.89M 7.02M 10.31M
Other Working Capital
n/a -1.9M -806K
Other Non-Cash Items
n/a 3.13M 803K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
n/a -2.7M -1.53M
Operating Cash Flow
-78.18M -67.09M -59.53M
Capital Expenditures
-105K -314K -1.26M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-413.71M -69.5M -45.31M
Sales Maturities Of Investments
127M 60M 90M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-286.81M -9.81M 43.43M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a 115K 141K
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
216.42M 2.88M 89.6M
Financial Cash Flow
255.62M 2.88M 89.6M
Net Cash Flow
-109.37M -74.02M 73.5M
Free Cash Flow
-78.28M -67.4M -60.8M